Structure

Physi-Chem Properties

Molecular Weight:  474.33
Volume:  511.956
LogP:  3.306
LogD:  2.266
LogS:  -3.525
# Rotatable Bonds:  5
TPSA:  97.99
# H-Bond Aceptor:  5
# H-Bond Donor:  4
# Rings:  4
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.441
Synthetic Accessibility Score:  5.351
Fsp3:  0.828
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.271
MDCK Permeability:  9.681482879386749e-06
Pgp-inhibitor:  0.893
Pgp-substrate:  0.936
Human Intestinal Absorption (HIA):  0.014
20% Bioavailability (F20%):  0.961
30% Bioavailability (F30%):  0.965

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.791
Plasma Protein Binding (PPB):  88.4508285522461%
Volume Distribution (VD):  0.976
Pgp-substrate:  2.7695367336273193%

ADMET: Metabolism

CYP1A2-inhibitor:  0.004
CYP1A2-substrate:  0.155
CYP2C19-inhibitor:  0.017
CYP2C19-substrate:  0.891
CYP2C9-inhibitor:  0.074
CYP2C9-substrate:  0.244
CYP2D6-inhibitor:  0.002
CYP2D6-substrate:  0.08
CYP3A4-inhibitor:  0.794
CYP3A4-substrate:  0.576

ADMET: Excretion

Clearance (CL):  4.135
Half-life (T1/2):  0.752

ADMET: Toxicity

hERG Blockers:  0.043
Human Hepatotoxicity (H-HT):  0.179
Drug-inuced Liver Injury (DILI):  0.057
AMES Toxicity:  0.022
Rat Oral Acute Toxicity:  0.017
Maximum Recommended Daily Dose:  0.332
Skin Sensitization:  0.09
Carcinogencity:  0.084
Eye Corrosion:  0.004
Eye Irritation:  0.016
Respiratory Toxicity:  0.501

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC473170

Natural Product ID:  NPC473170
Common Name*:   DCYOPZMJKBYLCO-QJDZRUNDSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  DCYOPZMJKBYLCO-QJDZRUNDSA-N
Standard InCHI:  InChI=1S/C29H46O5/c1-16(13-23(32)25(33)26(3,4)34)19-8-10-28(6)21(19)14-22(31)24-27(5)15-18(30)12-17(2)20(27)9-11-29(24,28)7/h12,16,20,22-25,31-34H,8-11,13-15H2,1-7H3/t16-,20+,22+,23+,24+,25-,27+,28+,29+/m1/s1
SMILES:  CC1=CC(=O)CC2(C1CCC3(C2C(CC4=C(CCC43C)C(C)CC(C(C(C)(C)O)O)O)O)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3632950
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0001194] Oxosteroids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30648 Alisma orientale Species Alismataceae Eukaryota rhizome n.a. n.a. PMID[10560729]
NPO30648 Alisma orientale Species Alismataceae Eukaryota n.a. rhizome n.a. PMID[17541191]
NPO30648 Alisma orientale Species Alismataceae Eukaryota Rhizome n.a. n.a. PMID[26425784]
NPO30648 Alisma orientale Species Alismataceae Eukaryota n.a. tuber n.a. PMID[26666273]
NPO30648 Alisma orientale Species Alismataceae Eukaryota n.a. n.a. n.a. Database[HerDing]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT203 Individual Protein Carboxylesterase 2 Homo sapiens IC50 = 2020.0 nM PMID[524840]
NPT203 Individual Protein Carboxylesterase 2 Homo sapiens Ki = 1760.0 nM PMID[524840]
NPT540 Individual Protein Bile acid receptor FXR Homo sapiens EC50 = 5640.0 nM PMID[524841]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC473170 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9231 High Similarity NPC473172
0.9032 High Similarity NPC473164
0.9022 High Similarity NPC472977
0.9022 High Similarity NPC472976
0.9011 High Similarity NPC155304
0.9 High Similarity NPC31985
0.9 High Similarity NPC32830
0.9 High Similarity NPC1015
0.8989 High Similarity NPC469314
0.8989 High Similarity NPC469317
0.8989 High Similarity NPC241875
0.8889 High Similarity NPC328539
0.8817 High Similarity NPC473162
0.8804 High Similarity NPC185936
0.8804 High Similarity NPC472978
0.8804 High Similarity NPC473167
0.8804 High Similarity NPC168027
0.8791 High Similarity NPC77263
0.8791 High Similarity NPC86319
0.8791 High Similarity NPC119416
0.8791 High Similarity NPC469319
0.8791 High Similarity NPC229871
0.8791 High Similarity NPC275740
0.8791 High Similarity NPC250592
0.8778 High Similarity NPC90652
0.8778 High Similarity NPC475740
0.8764 High Similarity NPC470574
0.8763 High Similarity NPC473424
0.8763 High Similarity NPC477915
0.875 High Similarity NPC316964
0.875 High Similarity NPC64600
0.8737 High Similarity NPC18509
0.8737 High Similarity NPC474938
0.8737 High Similarity NPC474785
0.8723 High Similarity NPC200702
0.8696 High Similarity NPC85173
0.8687 High Similarity NPC149047
0.8681 High Similarity NPC131470
0.8681 High Similarity NPC143767
0.8681 High Similarity NPC471722
0.8681 High Similarity NPC470417
0.8681 High Similarity NPC158778
0.8673 High Similarity NPC264048
0.8673 High Similarity NPC191892
0.8667 High Similarity NPC31564
0.8667 High Similarity NPC474778
0.8667 High Similarity NPC145879
0.8667 High Similarity NPC474732
0.8667 High Similarity NPC474733
0.8632 High Similarity NPC471463
0.8632 High Similarity NPC249954
0.8632 High Similarity NPC117133
0.8617 High Similarity NPC240617
0.8617 High Similarity NPC196485
0.8617 High Similarity NPC245972
0.8617 High Similarity NPC471207
0.8617 High Similarity NPC166906
0.8614 High Similarity NPC214644
0.8614 High Similarity NPC41405
0.8602 High Similarity NPC473166
0.8602 High Similarity NPC131872
0.86 High Similarity NPC83744
0.86 High Similarity NPC220229
0.86 High Similarity NPC477916
0.86 High Similarity NPC475060
0.8587 High Similarity NPC472973
0.8587 High Similarity NPC474245
0.8587 High Similarity NPC186688
0.8586 High Similarity NPC204833
0.8586 High Similarity NPC209502
0.8571 High Similarity NPC473163
0.8571 High Similarity NPC58063
0.8557 High Similarity NPC110149
0.8557 High Similarity NPC144956
0.8556 High Similarity NPC469948
0.8556 High Similarity NPC197823
0.8539 High Similarity NPC86370
0.8529 High Similarity NPC5284
0.8526 High Similarity NPC259286
0.8526 High Similarity NPC317586
0.8526 High Similarity NPC470016
0.8515 High Similarity NPC329417
0.8515 High Similarity NPC217201
0.8511 High Similarity NPC109305
0.8511 High Similarity NPC472930
0.8511 High Similarity NPC69454
0.8511 High Similarity NPC475255
0.8511 High Similarity NPC274046
0.8511 High Similarity NPC198074
0.85 High Similarity NPC296945
0.85 High Similarity NPC202167
0.85 High Similarity NPC260268
0.85 High Similarity NPC150531
0.85 High Similarity NPC49958
0.85 High Similarity NPC152695
0.85 High Similarity NPC476027
0.85 High Similarity NPC85829
0.85 High Similarity NPC97202
0.85 High Similarity NPC214264
0.85 High Similarity NPC48733
0.85 High Similarity NPC319077
0.85 High Similarity NPC50692
0.85 High Similarity NPC302607
0.85 High Similarity NPC171137
0.8495 Intermediate Similarity NPC183283
0.8495 Intermediate Similarity NPC126993
0.8495 Intermediate Similarity NPC48010
0.8478 Intermediate Similarity NPC292491
0.8478 Intermediate Similarity NPC310752
0.8478 Intermediate Similarity NPC474677
0.8478 Intermediate Similarity NPC53911
0.8469 Intermediate Similarity NPC469327
0.8462 Intermediate Similarity NPC72133
0.8454 Intermediate Similarity NPC114274
0.8444 Intermediate Similarity NPC85774
0.8444 Intermediate Similarity NPC59453
0.8444 Intermediate Similarity NPC221758
0.8444 Intermediate Similarity NPC214043
0.8438 Intermediate Similarity NPC96859
0.8438 Intermediate Similarity NPC328162
0.8438 Intermediate Similarity NPC305483
0.8438 Intermediate Similarity NPC473158
0.8438 Intermediate Similarity NPC192428
0.8431 Intermediate Similarity NPC11710
0.8427 Intermediate Similarity NPC151519
0.8427 Intermediate Similarity NPC212083
0.8421 Intermediate Similarity NPC103527
0.8421 Intermediate Similarity NPC474690
0.8421 Intermediate Similarity NPC8993
0.8421 Intermediate Similarity NPC111015
0.8421 Intermediate Similarity NPC196227
0.8416 Intermediate Similarity NPC165873
0.8409 Intermediate Similarity NPC2482
0.8404 Intermediate Similarity NPC473998
0.8404 Intermediate Similarity NPC475806
0.8404 Intermediate Similarity NPC86266
0.8404 Intermediate Similarity NPC110657
0.8404 Intermediate Similarity NPC116726
0.8404 Intermediate Similarity NPC272746
0.8404 Intermediate Similarity NPC189520
0.8404 Intermediate Similarity NPC63748
0.8404 Intermediate Similarity NPC472975
0.8404 Intermediate Similarity NPC212301
0.84 Intermediate Similarity NPC75531
0.84 Intermediate Similarity NPC149124
0.8387 Intermediate Similarity NPC26959
0.8387 Intermediate Similarity NPC309603
0.8387 Intermediate Similarity NPC473999
0.8387 Intermediate Similarity NPC268406
0.8387 Intermediate Similarity NPC475921
0.8387 Intermediate Similarity NPC477943
0.8387 Intermediate Similarity NPC474704
0.837 Intermediate Similarity NPC141292
0.837 Intermediate Similarity NPC138756
0.837 Intermediate Similarity NPC472324
0.8367 Intermediate Similarity NPC83709
0.8365 Intermediate Similarity NPC152117
0.8365 Intermediate Similarity NPC234042
0.8351 Intermediate Similarity NPC161147
0.8351 Intermediate Similarity NPC473161
0.8351 Intermediate Similarity NPC190554
0.8351 Intermediate Similarity NPC108078
0.835 Intermediate Similarity NPC239097
0.8333 Intermediate Similarity NPC30677
0.8333 Intermediate Similarity NPC37787
0.8333 Intermediate Similarity NPC278648
0.8333 Intermediate Similarity NPC139570
0.8333 Intermediate Similarity NPC472932
0.8333 Intermediate Similarity NPC280725
0.8333 Intermediate Similarity NPC473415
0.8333 Intermediate Similarity NPC65941
0.8333 Intermediate Similarity NPC476082
0.8333 Intermediate Similarity NPC469329
0.8333 Intermediate Similarity NPC180950
0.8333 Intermediate Similarity NPC180557
0.8333 Intermediate Similarity NPC271195
0.8317 Intermediate Similarity NPC323834
0.8317 Intermediate Similarity NPC60681
0.8316 Intermediate Similarity NPC474736
0.8316 Intermediate Similarity NPC12722
0.8316 Intermediate Similarity NPC107674
0.8316 Intermediate Similarity NPC79117
0.8316 Intermediate Similarity NPC134826
0.8316 Intermediate Similarity NPC141497
0.8316 Intermediate Similarity NPC170220
0.83 Intermediate Similarity NPC311612
0.83 Intermediate Similarity NPC247957
0.83 Intermediate Similarity NPC475050
0.83 Intermediate Similarity NPC249187
0.83 Intermediate Similarity NPC239716
0.8298 Intermediate Similarity NPC472325
0.8298 Intermediate Similarity NPC136801
0.8298 Intermediate Similarity NPC134321
0.8298 Intermediate Similarity NPC191684
0.8298 Intermediate Similarity NPC128672
0.8286 Intermediate Similarity NPC73300
0.8286 Intermediate Similarity NPC108721
0.8286 Intermediate Similarity NPC255017
0.8283 Intermediate Similarity NPC476897
0.828 Intermediate Similarity NPC474925

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC473170 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9 High Similarity NPD5328 Approved
0.8804 High Similarity NPD6079 Approved
0.8737 High Similarity NPD4755 Approved
0.8667 High Similarity NPD3618 Phase 1
0.8557 High Similarity NPD4700 Approved
0.8557 High Similarity NPD4696 Approved
0.8557 High Similarity NPD5286 Approved
0.8557 High Similarity NPD5285 Approved
0.8444 Intermediate Similarity NPD4786 Approved
0.8438 Intermediate Similarity NPD4697 Phase 3
0.8438 Intermediate Similarity NPD5222 Approved
0.8438 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.8438 Intermediate Similarity NPD5221 Approved
0.8427 Intermediate Similarity NPD3667 Approved
0.8384 Intermediate Similarity NPD5226 Approved
0.8384 Intermediate Similarity NPD4633 Approved
0.8384 Intermediate Similarity NPD5225 Approved
0.8384 Intermediate Similarity NPD5224 Approved
0.8384 Intermediate Similarity NPD5211 Phase 2
0.8351 Intermediate Similarity NPD5173 Approved
0.8317 Intermediate Similarity NPD6675 Approved
0.8317 Intermediate Similarity NPD7128 Approved
0.8317 Intermediate Similarity NPD5739 Approved
0.8317 Intermediate Similarity NPD6402 Approved
0.8316 Intermediate Similarity NPD4202 Approved
0.83 Intermediate Similarity NPD5175 Approved
0.83 Intermediate Similarity NPD5174 Approved
0.8283 Intermediate Similarity NPD5223 Approved
0.8242 Intermediate Similarity NPD3133 Approved
0.8242 Intermediate Similarity NPD3665 Phase 1
0.8242 Intermediate Similarity NPD3666 Approved
0.8218 Intermediate Similarity NPD5141 Approved
0.8211 Intermediate Similarity NPD7515 Phase 2
0.8191 Intermediate Similarity NPD4753 Phase 2
0.8173 Intermediate Similarity NPD4634 Approved
0.8155 Intermediate Similarity NPD6881 Approved
0.8155 Intermediate Similarity NPD7320 Approved
0.8155 Intermediate Similarity NPD6899 Approved
0.8137 Intermediate Similarity NPD4768 Approved
0.8137 Intermediate Similarity NPD4767 Approved
0.8119 Intermediate Similarity NPD4754 Approved
0.8077 Intermediate Similarity NPD6372 Approved
0.8077 Intermediate Similarity NPD6373 Approved
0.8058 Intermediate Similarity NPD5697 Approved
0.8058 Intermediate Similarity NPD5701 Approved
0.8019 Intermediate Similarity NPD8297 Approved
0.8 Intermediate Similarity NPD7102 Approved
0.8 Intermediate Similarity NPD7290 Approved
0.8 Intermediate Similarity NPD6883 Approved
0.7981 Intermediate Similarity NPD4729 Approved
0.7981 Intermediate Similarity NPD4730 Approved
0.7981 Intermediate Similarity NPD5128 Approved
0.7925 Intermediate Similarity NPD6650 Approved
0.7925 Intermediate Similarity NPD8130 Phase 1
0.7925 Intermediate Similarity NPD6617 Approved
0.7925 Intermediate Similarity NPD6869 Approved
0.7925 Intermediate Similarity NPD6649 Approved
0.7925 Intermediate Similarity NPD6847 Approved
0.7905 Intermediate Similarity NPD6014 Approved
0.7905 Intermediate Similarity NPD6012 Approved
0.7905 Intermediate Similarity NPD6013 Approved
0.7872 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7857 Intermediate Similarity NPD7748 Approved
0.785 Intermediate Similarity NPD6882 Approved
0.7849 Intermediate Similarity NPD3668 Phase 3
0.783 Intermediate Similarity NPD5249 Phase 3
0.783 Intermediate Similarity NPD5247 Approved
0.783 Intermediate Similarity NPD5248 Approved
0.783 Intermediate Similarity NPD5250 Approved
0.783 Intermediate Similarity NPD5251 Approved
0.7826 Intermediate Similarity NPD4223 Phase 3
0.7826 Intermediate Similarity NPD4221 Approved
0.781 Intermediate Similarity NPD6011 Approved
0.78 Intermediate Similarity NPD6083 Phase 2
0.78 Intermediate Similarity NPD6084 Phase 2
0.7778 Intermediate Similarity NPD5210 Approved
0.7778 Intermediate Similarity NPD4632 Approved
0.7778 Intermediate Similarity NPD4629 Approved
0.7766 Intermediate Similarity NPD5329 Approved
0.7757 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7757 Intermediate Similarity NPD5217 Approved
0.7757 Intermediate Similarity NPD5215 Approved
0.7757 Intermediate Similarity NPD5216 Approved
0.7755 Intermediate Similarity NPD6399 Phase 3
0.7727 Intermediate Similarity NPD7115 Discovery
0.7684 Intermediate Similarity NPD5279 Phase 3
0.7664 Intermediate Similarity NPD5169 Approved
0.7664 Intermediate Similarity NPD5135 Approved
0.7664 Intermediate Similarity NPD5134 Clinical (unspecified phase)
0.766 Intermediate Similarity NPD4197 Approved
0.7642 Intermediate Similarity NPD5168 Approved
0.7624 Intermediate Similarity NPD7902 Approved
0.7609 Intermediate Similarity NPD4695 Discontinued
0.7609 Intermediate Similarity NPD7525 Registered
0.7593 Intermediate Similarity NPD5127 Approved
0.7547 Intermediate Similarity NPD6412 Phase 2
0.7522 Intermediate Similarity NPD6319 Approved
0.7522 Intermediate Similarity NPD6059 Approved
0.7522 Intermediate Similarity NPD6054 Approved
0.75 Intermediate Similarity NPD6684 Approved
0.75 Intermediate Similarity NPD4693 Phase 3
0.75 Intermediate Similarity NPD4623 Approved
0.75 Intermediate Similarity NPD4690 Approved
0.75 Intermediate Similarity NPD5205 Approved
0.75 Intermediate Similarity NPD7334 Approved
0.75 Intermediate Similarity NPD4689 Approved
0.75 Intermediate Similarity NPD7146 Approved
0.75 Intermediate Similarity NPD7521 Approved
0.75 Intermediate Similarity NPD4688 Approved
0.75 Intermediate Similarity NPD4138 Approved
0.75 Intermediate Similarity NPD6409 Approved
0.75 Intermediate Similarity NPD4519 Discontinued
0.75 Intermediate Similarity NPD5330 Approved
0.7477 Intermediate Similarity NPD6274 Approved
0.7453 Intermediate Similarity NPD6008 Approved
0.7444 Intermediate Similarity NPD7339 Approved
0.7444 Intermediate Similarity NPD6942 Approved
0.7434 Intermediate Similarity NPD7100 Approved
0.7434 Intermediate Similarity NPD7101 Approved
0.7426 Intermediate Similarity NPD5695 Phase 3
0.7423 Intermediate Similarity NPD3573 Approved
0.7411 Intermediate Similarity NPD6009 Approved
0.7396 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD6370 Approved
0.7391 Intermediate Similarity NPD3617 Approved
0.7387 Intermediate Similarity NPD5167 Approved
0.7379 Intermediate Similarity NPD7638 Approved
0.7379 Intermediate Similarity NPD5696 Approved
0.7368 Intermediate Similarity NPD4788 Approved
0.7363 Intermediate Similarity NPD3701 Clinical (unspecified phase)
0.7347 Intermediate Similarity NPD6672 Approved
0.7347 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7347 Intermediate Similarity NPD5737 Approved
0.7347 Intermediate Similarity NPD6903 Approved
0.7345 Intermediate Similarity NPD6335 Approved
0.7327 Intermediate Similarity NPD7900 Approved
0.7327 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7321 Intermediate Similarity NPD6868 Approved
0.732 Intermediate Similarity NPD5690 Phase 2
0.732 Intermediate Similarity NPD5280 Approved
0.732 Intermediate Similarity NPD4694 Approved
0.7312 Intermediate Similarity NPD7645 Phase 2
0.7308 Intermediate Similarity NPD7640 Approved
0.7308 Intermediate Similarity NPD7639 Approved
0.7304 Intermediate Similarity NPD6908 Approved
0.7304 Intermediate Similarity NPD6909 Approved
0.7304 Intermediate Similarity NPD6016 Approved
0.7304 Intermediate Similarity NPD6015 Approved
0.73 Intermediate Similarity NPD6411 Approved
0.7265 Intermediate Similarity NPD7492 Approved
0.7257 Intermediate Similarity NPD6317 Approved
0.7255 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD5988 Approved
0.7212 Intermediate Similarity NPD4225 Approved
0.7203 Intermediate Similarity NPD6616 Approved
0.7193 Intermediate Similarity NPD6313 Approved
0.7193 Intermediate Similarity NPD6314 Approved
0.7179 Intermediate Similarity NPD7604 Phase 2
0.7174 Intermediate Similarity NPD6933 Approved
0.7155 Intermediate Similarity NPD5983 Phase 2
0.7143 Intermediate Similarity NPD7078 Approved
0.7143 Intermediate Similarity NPD8293 Discontinued
0.7129 Intermediate Similarity NPD5284 Approved
0.7129 Intermediate Similarity NPD5281 Approved
0.7128 Intermediate Similarity NPD4195 Approved
0.71 Intermediate Similarity NPD6904 Approved
0.71 Intermediate Similarity NPD6101 Approved
0.71 Intermediate Similarity NPD7285 Clinical (unspecified phase)
0.71 Intermediate Similarity NPD6080 Approved
0.71 Intermediate Similarity NPD5764 Clinical (unspecified phase)
0.71 Intermediate Similarity NPD6673 Approved
0.7091 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD7736 Approved
0.7079 Intermediate Similarity NPD4137 Phase 3
0.7065 Intermediate Similarity NPD3703 Phase 2
0.7059 Intermediate Similarity NPD7507 Approved
0.7059 Intermediate Similarity NPD6336 Discontinued
0.7053 Intermediate Similarity NPD8259 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD1696 Phase 3
0.7034 Intermediate Similarity NPD8328 Phase 3
0.7009 Intermediate Similarity NPD6291 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD4747 Approved
0.7 Intermediate Similarity NPD4691 Approved
0.6961 Remote Similarity NPD8034 Phase 2
0.6961 Remote Similarity NPD8035 Phase 2
0.6957 Remote Similarity NPD6926 Approved
0.6957 Remote Similarity NPD6924 Approved
0.6942 Remote Similarity NPD6033 Approved
0.6932 Remote Similarity NPD7331 Phase 2
0.6923 Remote Similarity NPD4809 Clinical (unspecified phase)
0.6923 Remote Similarity NPD4808 Clinical (unspecified phase)
0.6889 Remote Similarity NPD3699 Clinical (unspecified phase)
0.6889 Remote Similarity NPD3700 Clinical (unspecified phase)
0.6887 Remote Similarity NPD5290 Discontinued
0.6885 Remote Similarity NPD7319 Approved
0.6875 Remote Similarity NPD7509 Discontinued
0.6863 Remote Similarity NPD4096 Approved
0.6847 Remote Similarity NPD5345 Clinical (unspecified phase)
0.6847 Remote Similarity NPD6686 Approved
0.6838 Remote Similarity NPD4522 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data